Key result
Peak levels of CD14++CD16- monocytes were significantly higher in STEMI compared with non-STEMI patients (631.6 vs. 539.6/mm, P=0.003) and correlated with worse angiographic characteristics.
Population
85 patients, including 30 with acute ST elevation myocardial infarction, 30 with non-STEMI, and 25 with…
Design
Cohort
Follow-up
7 days
Authors
Loading...
Monocyte subset differences associate with STEMI severity; hypothesis-generating for risk stratification and targeted therapies.
Observational (n=85)
Absolute Event Rate: 631.6% vs 539.6%
p-value: p=0.003
Monocyte heterogeneity differs between STEMI and non-STEMI patients and is associated with worse angiographic characteristics, including total occlusion and no reflow.
Arslan et al. (2013) conducted an observational in Myocardial infarction (STEMI and non-STEMI) and stable angina pectoris (n=85). STEMI vs. non-STEMI and stable angina pectoris was evaluated on Peak levels of CD14++CD16- monocytes (/mm) (p=0.003). Peak levels of CD14++CD16- monocytes were significantly higher in STEMI compared with non-STEMI patients (631.6 vs. 539.6/mm, P=0.003) and correlated with worse angiographic characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: